Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy
L Vergne, CT Kane, C Laurent, N Diakhaté… - Aids, 2003 - journals.lww.com
Objective To monitor the prevalence of antiretroviral (ARV)-resistant HIV-1 viruses, and the
genotypic mutations in patients enrolled in the Senegalese initiative for access to …
genotypic mutations in patients enrolled in the Senegalese initiative for access to …
Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy.
L Vergne, CT Kane, C Laurent, N Diakhaté… - AIDS (London …, 2003 - europepmc.org
OBJECTIVE: To monitor the prevalence of antiretroviral (ARV)-resistant HIV-1 viruses, and
the genotypic mutations in patients enrolled in the Senegalese initiative for access to …
the genotypic mutations in patients enrolled in the Senegalese initiative for access to …
Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy
L Vergne, CT Kane, C Laurent… - AIDS (London …, 2003 - pubmed.ncbi.nlm.nih.gov
Objective To monitor the prevalence of antiretroviral (ARV)-resistant HIV-1 viruses, and the
genotypic mutations in patients enrolled in the Senegalese initiative for access to …
genotypic mutations in patients enrolled in the Senegalese initiative for access to …
[引用][C] Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy
L VERGNE, CT KANE, I LANIECE… - AIDS …, 2003 - pascal-francis.inist.fr
Author VERGNE, Laurence 1; COUMBA TOURE KANE 2; LANIECE, Isabelle 1; PEETERS,
Martine 1; NDOYE, Ibrahima 5; MBOUP, Souleymane 2; DELAPORTE, Eric 1; LAURENT …
Martine 1; NDOYE, Ibrahima 5; MBOUP, Souleymane 2; DELAPORTE, Eric 1; LAURENT …
Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy
L Vergne, KC Touré, C Laurent, N Diakhaté… - 2003 - documentation.ird.fr
Objective: To monitor the prevalence of antiretroviral (ARV)-resistant HIV-l viruses, and the
genotypic mutations in patients enrolled in the Senegalese initiative for access to …
genotypic mutations in patients enrolled in the Senegalese initiative for access to …
Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy.
L Vergne, CT Kane, C Laurent, N Diakhaté… - 2003 - cabidigitallibrary.org
Objective: To monitor the prevalence of antiretroviral (ARV)-resistant HIV-1 viruses, and the
genotypic mutations in patients enrolled in the Senegalese initiative for access to …
genotypic mutations in patients enrolled in the Senegalese initiative for access to …
Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy
L Vergne, KC Touré, C Laurent, N Diakhaté… - 2003 - documentation.ird.fr
Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of
access to antiretroviral therapy- fdi:010031375- Horizon Horizon - Listes de publications Par …
access to antiretroviral therapy- fdi:010031375- Horizon Horizon - Listes de publications Par …